Zuellig Pharma Signs Exclusive Distribution Deal with Regeneron to Launch Libtayo
Regeneron is a biotechnology company that invents, develops and commercialises life-transforming medicines for people with serious diseases.
Regeneron | 28/08/2024 | By Aishwarya
Regeneron's Covid treatment review extended by FDA
The U.S. FDA is broadening the survey date for Regeneron Pharmaceuticals' COVID-19 immune response mixed drink back by 90 days. The choice was made after information showed it might assist with forestalling disease.
Regeneron | 16/04/2022 | By Sudeep Soparkar | 318
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy